Ocugen to resume Covaxin trials 'immediately' after FDA lifts its latest clinical hold
The Food and Drug Administration has lifted a clinical hold on Ocugen's late-stage clinical trials of a Covid-19 vaccine it is attempting to bring to the United States. The vaccine, called Covaxin, was developed by Bharat Biotech of India. Malvern-based Ocugen (NASDAQ: OCGN) last year formed a partnership with Bharat to co-develop and market Covaxin in North America. The deal, which covers the United States and Canada, was expanded last month to also include Mexi co. In April, according to Ocugen,… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 23, 2022 Category: Pharmaceuticals Authors: John George Source Type: news

Vaccination After SARS-CoV-2 Infection May Cut Long COVID Risk
MONDAY, May 23, 2022 -- For adults who test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), COVID-19 vaccination after infection is associated with a reduced likelihood of long COVID symptoms, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2022 Category: Pharmaceuticals Source Type: news

Pfizer Says Strong Response From 3 Covid Shots in Young Children
The preliminary results appeared to show that three doses of the vaccine worked better than two. (Source: NYT Health)
Source: NYT Health - May 23, 2022 Category: Consumer Health News Authors: Sharon LaFraniere Tags: Pfizer Inc BioNTech SE Vaccination and Immunization Coronavirus (2019-nCoV) Source Type: news

Three-dose Covid-19 vaccine produces strong immune response in young children, Pfizer and BioNTech say
Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week. (Source: CNN.com - Health)
Source: CNN.com - Health - May 23, 2022 Category: Consumer Health News Source Type: news

Pfizer covid shot 80 percent effective in young kids, early data shows
The data is a step toward a vaccine for infants, toddlers and children younger than 5 — the last age group to lack access to a coronavirus vaccine in the United States. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 23, 2022 Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news

Pfizer Says 3 COVID-19 Shots Protect Children Under 5
Three doses of Pfizer’s COVID-19 vaccine offer strong protection for children younger than 5, the company announced Monday. Pfizer plans to give the data to U.S. regulators later this week in a step toward letting the littlest kids get the shots. The news comes after months of anxious waiting by parents desperate to vaccinate their babies, toddlers, and preschoolers, especially as COVID-19 cases once again are rising. The 18 million tots under 5 are the only group in the U.S. not yet eligible for COVID-19 vaccination. The Food and Drug Administration has begun evaluating data from rival Moderna, which hopes to begin ...
Source: TIME: Health - May 23, 2022 Category: Consumer Health News Authors: Lauran Neergaard / AP Tags: Uncategorized COVID-19 healthscienceclimate News Desk wire Source Type: news

Three-dose Covid-19 vaccine produces strong immune response in children ages 6 months to 5 years, Pfizer and BioNTech say
Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The vaccine makers said they will finish submitting the trial data to the US Food and Drug Administration this week. (Source: CNN.com - Health)
Source: CNN.com - Health - May 23, 2022 Category: Consumer Health News Source Type: news

Pfizer Says Three Shots Of Low-Dose Vaccine Generates ‘Strong Immune Response’ In Kids Under 5
Pfizer and BioNTech said they will finish submitting data to the FDA “this week” as they seek authorization for the shots, which aren’t yet available to children under 5. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 23, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Science /science Healthcare /healthcare Breaking breaking-news Coronavirus Source Type: news

Pfizer says three COVID-19 vaccine doses protect kids under 5, company plans to give data to U.S. regulators this week
(Source: ABC News: Health)
Source: ABC News: Health - May 23, 2022 Category: Consumer Health News Tags: Health Source Type: news

Pfizer to seek US emergency approval of Covid vaccine for under 5s
Jabs for youngest children offer potential new market amid global glut of adult doses (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 23, 2022 Category: Pharmaceuticals Source Type: news

South Africa: SA Has Administered 35,744,528 Vaccines to Date
[SAnews.gov.za] South Africa has administered a total of 2 804 COVID-19 vaccines in the last 24 hours, bringing the total number of vaccines to 35 744 528 to date. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 23, 2022 Category: African Health Source Type: news

Africa: Covax Calls for Urgent Action to Close Vaccine Equity Gap
[WHO] COVAX has access to enough COVID-19 vaccines to help protect 70% of the population in 91 lower income countries.Demand and uptake are low, with low-income countries remaining furthest behind.To close the global vaccine equity gap, COVAX calls on countries to set ambitious targets for implementation and on all partners to ensure countries have the resources needed to accelerate and expand national strategies. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 23, 2022 Category: African Health Source Type: news

Alex Jones ’ Unfounded Claims That Monkeypox Outbreak Due To Covid-19 Vaccines
Here are the issues with what Jones and some others have been claiming about the AstraZeneca and Johnson& Johnson Covid-19 vaccines. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 22, 2022 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma Source Type: news

The COVID-19 pandemic is 'most certainly not over,' WHO's health chief says
The UN health agency's director general told officials gathered in Geneva for the opening of the WHO's annual meeting that "declining testing and sequencing means we are blinding ourselves to the evolution of the virus." He also noted that almost one billion people still haven't been vaccinated. (Source: CBC | Health)
Source: CBC | Health - May 22, 2022 Category: Consumer Health News Tags: News/World Source Type: news

3 Air Force cadets who refused vaccine won't be commissioned
WASHINGTON — Three cadets at the U.S. Air Force Academy who have refused the COVID-19 vaccine will not be commissioned as military officers but will graduate with bachelor's degrees, the academy... #militaryofficers #cadets #airforce (Source: Reuters: Health)
Source: Reuters: Health - May 22, 2022 Category: Consumer Health News Source Type: news